Background and Objectives: Peripheral nerve injury initiates a series of degenerative, inflammatory, and reparative responses. Piracetam and hyperbaric oxygen (HBO) have been proposed as potential therapeutic interventions; however, their effects during the early phase following sciatic nerve injury require further investigation. This study evaluated early histopathological and circulating biochemical responses to piracetam and HBO in a rat model of sciatic nerve injury. Materials and Methods: Forty male Wistar Albino rats were randomly allocated to four groups following experimental sciatic nerve injury: an untreated injury control group (Group K), a hyperbaric oxygen therapy group (Group HBO), an intraperitoneal piracetam group (Group P), and a combined hyperbaric oxygen plus piracetam group (Group HBO + P). After 14 days, the rats were euthanised, and sciatic nerve tissues and blood samples were collected for histopathological and biochemical analyses. Results: No statistically significant differences were observed among the four groups with respect to axonal continuity, capillary formation, or myelin sheath regeneration. Fibroblast density was increased in Group P compared with Group K (p = 0.025), while no significant differences were detected among the remaining groups. Inflammatory cell counts were higher in Group P than in Group K (p = 0.037) and elevated in Group HBO + P compared with Group K (p = 0.014). Hypoxia-inducible factor-1 alpha (HIF-1α) expression was highest in Group K. Additionally, neuron-specific enolase levels were significantly increased in Group P compared with Group K (p = 0.006). Conclusions: Under the conditions of this 14-day experimental study, piracetam and HBO were associated with differences in selected circulating biochemical parameters but did not produce statistically significant improvements in the assessed histopathological indices. The findings were interpreted as early responses to treatment, and longer follow-up studies are needed to determine whether these changes translate into sustained axonal regeneration or functional recovery.
Background: Pharmacological neuroprotection and adjuvant physical therapies, including piracetam and hyperbaric oxygen therapy, have emerged as potential strategies to enhance nerve regeneration. We aimed to assess the effects of piracetam and hyperbaric oxygen on peripheral nerve regeneration. Methods: Forty male Wistar Albino rats were randomly allocated to four groups following experimental sciatic nerve injury: standard care (Group K), hyperbaric oxygen therapy (Group HBO), intraperitoneal piracetam (Group P), and combined hyperbaric oxygen plus piracetam (Group C). After 14 days, the rats were sacrificed, and sciatic nerve tissues and blood samples were collected for histopathological and biochemical analyses. Results: No statistically significant differences were observed among the four groups with respect to axonal continuity, capillary formation, or myelin sheath regeneration. Fibroblast density was increased in Group P compared with Group K (p = 0.025), while no significant differences were detected among the remaining groups. Inflammatory cell counts were higher in Group P than in Group K (p = 0.037) and elevated in Group C compared with Group K (p = 0.014). Hypoxia-inducible factor-1 alpha (HIF-1α) expression was highest in Group K. Additionally, neuron-specific enolase levels were significantly increased in Group P compared with Group K (p = 0.006). Conclusion: In this experimental model, neither piracetam nor hyperbaric oxygen therapy resulted in significant improvements in structural nerve regeneration parameters. However, distinct alterations in inflammatory and biochemical markers were observed, indicating that these interventions may modulate cellular and metabolic responses following sciatic nerve injury rather than directly enhancing axonal repair.
Artificial intelligence is a rising star in pathology. Applying artificial intelligence methods to pathology is a gleam of hope to reduce the workload of pathologists. Diagnosis in melanocytic lesions can be challenging. There are lesions that cannot be clearly addressed, not only for general pathologists, but even for dermatopathologists. Can artificial intelligence help us with this dilemmas? To find an answer we aimed to measure the contribution of artificial intelligence to the differential diagnosis of melanocytic lesions. We used machine learning in the first part and deep learning in the second part in order to measure artificial intelligence's contribution to the discrimination of melanocytic lesions. It has been observed that both methods can provide diagnostic support with high accuracy rates. Our study shows that we can get the support of artificial intelligence in the field of pathology. However, there are still issues to be discussed and resolved regarding the place of artificial intelligence in pathology.
Fracture healing remains a major challenge in orthopedic practice, and natural bioactive products have attracted increasing interest as supportive agents for bone regeneration. Apilarnil (drone larvae homogenate), a bee-derived natural product with antioxidant and anti-inflammatory properties, has not previously been investigated in fracture healing. This study evaluated the effects of oral apilarnil on experimental femoral fracture healing in rats. Forty-two male Wistar Albino rats underwent standardized closed femoral fracture fixation with intramedullary Kirschner wire stabilization and were randomly assigned to either a control group or an apilarnil-treated group receiving 400 mg/kg/day orally. Animals were sacrificed on postoperative days 15, 30, and 45. Fracture healing was assessed radiologically using the Lane and Sandhu scoring system, histopathologically using the Huo scoring system, and biomechanically by a three-point bending test. Histopathological scores were significantly higher in the apilarnil group on postoperative day 15 (p = 0.042), whereas no significant differences were observed at later time points. Biomechanical testing demonstrated significantly greater fracture strength in the apilarnil-treated group on postoperative days 30 (p = 0.001) and 45 (p = 0.004), while radiological scores did not differ significantly between groups throughout the study. These findings suggest that apilarnil may support fracture healing by enhancing early tissue repair and improving the biomechanical properties of healing bone, warranting further experimental and clinical investigation.